 |
PDBsum entry 4yyi
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Protein binding
|
PDB id
|
|
|
|
4yyi
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Protein binding
|
 |
|
Title:
|
 |
Crystal structure of brd9 bromodomain bound to an acetylated peptide
|
|
Structure:
|
 |
Bromodomain-containing protein 9. Chain: a, b, d, e. Fragment: bromodomain (unp residues 17-123). Synonym: rhabdomyosarcoma antigen mu-rms-40.8, brd9. Engineered: yes. Histone h4. Chain: c, f. Fragment: n-terminal tail (unp residues 2-12). Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: brd9, unq3040/pro9856. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
1.50Å
|
R-factor:
|
0.208
|
R-free:
|
0.242
|
|
|
Authors:
|
 |
Y.Tang,S.Bellon,A.G.Cochran,F.Poy
|
|
Key ref:
|
 |
E.M.Flynn
et al.
(2015).
A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications.
Structure,
23,
1801-1814.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Mar-15
|
Release date:
|
16-Sep-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9H8M2
(BRD9_HUMAN) -
Bromodomain-containing protein 9 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
597 a.a.
100 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
23:1801-1814
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications.
|
|
E.M.Flynn,
O.W.Huang,
F.Poy,
M.Oppikofer,
S.F.Bellon,
Y.Tang,
A.G.Cochran.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Bromodomains are epigenetic readers that are recruited to acetyllysine residues
in histone tails. Recent studies have identified non-acetyl acyllysine
modifications, raising the possibility that these might be read by bromodomains.
Profiling the nearly complete human bromodomain family revealed that while most
human bromodomains bind only the shorter acetyl and propionyl marks, the
bromodomains of BRD9, CECR2, and the second bromodomain of TAF1 also recognize
the longer butyryl mark. In addition, the TAF1 second bromodomain is capable of
binding crotonyl marks. None of the human bromodomains tested binds succinyl
marks. We characterized structurally and biochemically the binding to different
acyl groups, identifying bromodomain residues and structural attributes that
contribute to specificity. These studies demonstrate a surprising degree of
plasticity in some human bromodomains but no single factor controlling
specificity across the family. The identification of candidate butyryl- and
crotonyllysine readers supports the idea that these marks could have specific
physiological functions.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |